Page last updated: 2024-09-04

ruboxistaurin and DDD MPGNII

ruboxistaurin has been researched along with DDD MPGNII in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cox, AJ; Gilbert, RE; Gow, RM; Kelly, DJ; Kim, S; Langham, RG; Tokuyama, H; Zhang, Y1

Other Studies

1 other study(ies) available for ruboxistaurin and DDD MPGNII

ArticleYear
Protein kinase C β inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
    Nephrology (Carlton, Vic.), 2011, Volume: 16, Issue:7

    Topics: Animals; Antibodies, Monoclonal; Cell Line; Cell Proliferation; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix; Glomerulonephritis, Membranoproliferative; Immunoglobulin G; Indoles; Male; Maleimides; Mesangial Cells; Platelet-Derived Growth Factor; Protein Kinase C; Protein Kinase C beta; Protein Kinase Inhibitors; Proteinuria; Rats; Rats, Wistar; Thy-1 Antigens

2011